Analysis of the thymidylate synthase gene structure in colorectal cancer patients and its possible relation with the 5-fluorouracil drug response

Journal of Nucleic Acids

Volumn 2010, Issue , 2010, Pages

  Calascibetta, A ^a   Contino, Flavia ^a   Feo, S ^a   Gulotta, G ^a   Cajozzo, M ^a   Antona, A ^a   Sanguedolce, G ^a   Sanguedolce, R ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CATALYSIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; DRUG RESPONSE; ENZYME ANALYSIS; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENE STRUCTURE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; TUMOR LOCALIZATION;

EID: 80054088274     PISSN: 20900201     EISSN: 2090021X     Source Type: Journal    
DOI: 10.4061/2010/306754     Document Type: Article

References (19)

1. Santi D. V., McHenry C. S., Sommer H., Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 1974 13 3 471 481 2-s2.0-0015962412
2. Rose M. G., Farrell M. P., Schmitz J. C., Thymidylate synthase: a critical target for cancer chemotherapy. Clinical Colorectal Cancer 2002 1 4 220 229 2-s2.0-0036217711 (Pubitemid 34269382)
3. Shibata J., Aiba K., Shibata H., Minowa S., Horikoshi N., Detection and quantitation of thymidylate synthase mRNA in human colon adenocarcinoma cell line resistant to 5-fluorouracil by competitive PCR. Anticancer Research 1998 18 3 1457 1463 2-s2.0-0031875509 (Pubitemid 28342546)
4. Kaneda S., Takeishi K., Ayusawa D., Shimizu K., Seno T., Altman S., Role in translation of a triple tandemly repeated sequence in the 5′ -untranslated region of human thymidylate synthase mRNA. Nucleic Acids Research 1987 15 3 1259 1270 2-s2.0-0023134446 (Pubitemid 17012904)
5. Bertino J. R., Banerjee D., Is the measurement of thymidylate synthase to determine suitability for treatment with 5-fluoropyrimidines ready for prime time? Clinical Cancer Research 2003 9 4 1235 1239 2-s2.0-0037386688 (Pubitemid 36418371)
6. DiPaolo A., Chu E., The role of thymidylate synthase as a molecular biomarker. Clinical Cancer Research 2004 10 2 411 412 10.1158/1078-0432.CCR- 1198-03 2-s2.0-0842268403 (Pubitemid 38173975)
7. Popat S., Matakidou A., Houlston R. S., Thymidylate-synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis. Journal of Clinical Oncology 2004 22 3 529 536 10.1200/JCO.2004.05.064 2-s2.0-1442290323 (Pubitemid 41079782)
8. Johnston P. G., Lenz H. J., Leichman C. G., Danenberg K. D., Allegra J. C., Danenberg J. C., Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumours. Cancer Research 1995 55 1407 1412
9. Leichman C. G., Lenz H.-J., Leichman L., Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. Journal of Clinical Oncology 1997 15 10 3223 3229 2-s2.0-0030883708 (Pubitemid 27419335)
10. Sanguedolce R., Brumarescu I., Dardanoni G., Grassadonia A., Vultaggio G., Rausa L., Thymidylate synthase level and DNA-ploidy pattern as possible prognostic factors in human colorectal cancer: a preliminary study. Anticancer Research 1995 15 3 901 906 2-s2.0-0029046577
11. Findlay M. P. N., Cunningham D., Morgan G., Clinton S., Handcastle A., Aherne G. W., Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy. European Journal of Cancer 2005 41 2176 2183
12. Jastreboff M. M., Kedzierska B., Rode W., Altered thymidylate synthetase in 5-fluorodeoxyuridine-resistant Ehrlich ascites carcinoma cells. Biochemical Pharmacology 1983 32 14 2259 2267 10.1016/0006-2952(83)90236-8 2-s2.0-0020504093 (Pubitemid 13069231)
13. Bapat A. R., Zarow C., Danenberg P. V., Human leukemic cells resistant to 5-fluoro- 2′ -deoxyuridine contain a thymidylate synthetase with lower affinity for nucleotides. Journal of Biological Chemistry 1983 258 7 4130 4136 2-s2.0-0020957578 (Pubitemid 13080631)
14. Houghton P. J., Rahman A., Will C. L., Dolnick B. J., Houghton J. A., Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates. Cancer Research 1992 52 3 558 565 2-s2.0-0026503987
15. Berger S. H., Berger F. G., Thymidylate synthase as a determinant of 5-fluoro- 2′ -deoxyuridine response in human colonic tumor cell lines. Molecular Pharmacology 1988 34 4 474 479
16. Berger S. H., Barbour K. W., Berger F. G., A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro- 2′ -deoxyuridine in a human colon tumor cell line. Molecular Pharmacology 1988 34 4 480 484 2-s2.0-0023803472
17. Barbour K. W., Berger S. H., Berger F. G., Single amino acid substitution defines a naturally occurring genetic variant of human thymidylate synthase. Molecular Pharmacology 1990 37 4 515 518 2-s2.0-0025307988 (Pubitemid 20130794)
18. Barbour K. W., Hoganson D. K., Berger S. H., Berger F. G., A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro- 2′ -deoxyuridine in mammalian and bacterial cells. Molecular Pharmacology 1992 42 2 242 248 2-s2.0-0027081148 (Pubitemid 23026155)
19. Sanguedolce R., Alessandro R., De Leo G., Failure of detection of the tyrosine to histidine substitution at the residue 33 of thymidylate synthase in human colorectal cancer. A preliminary study. Anticancer Research 2000 20 6 4347 4350 2-s2.0-0020957578 (Pubitemid 32141784)